España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Lantern Pharma
LTRN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$3.69
0.09
2.50%
At close: -
$3.25
-0.44
-11.92%
After Hours: Jan 16, 5:24 PM EDT
Get Report
Comment
Lantern Pharma (LTRN) Forecast
News
Earnings
Lantern Pharma (LTRN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Lantern Pharma (NASDAQ:LTRN) Stock
Lantern Pharma Stock (NASDAQ: LTRN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 13, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Monday, December 09, 2024
Lantern Pharma shares are trading higher afte...
Benzinga Newsdesk
Lantern Pharma Enrolls First Patient In Taiwa...
Benzinga Newsdesk
Tuesday, December 03, 2024
Lantern Pharma shares are trading higher afte...
Benzinga Newsdesk
Lantern Pharma's Investigational Drug-Candida...
Benzinga Newsdesk
Tuesday, November 26, 2024
Lantern Pharma & Starlight Therapeutics Annou...
Benzinga Newsdesk
Tuesday, November 19, 2024
Lantern Pharma Doses First Patient In Japan F...
Benzinga Newsdesk
Thursday, November 07, 2024
Lantern Pharma Q3 2024 GAAP EPS $(0.42) Beats...
Benzinga Newsdesk
Tuesday, October 15, 2024
Lantern Pharma shares are trading higher afte...
Benzinga Newsdesk
Lantern Pharma's LP-184 Receives FDA Fast-Tra...
Benzinga Newsdesk
Monday, September 23, 2024
Lantern Pharma Receives Three FDA Rare Pediat...
Benzinga Newsdesk
Monday, August 12, 2024
Watching Lantern Pharma; Zacks Small Cap Rese...
Benzinga Newsdesk
Friday, August 09, 2024
Lantern Pharma shares are trading lower. The ...
Benzinga Newsdesk
Thursday, August 08, 2024
Lantern Pharma Q2 2024 GAAP EPS $(0.46) Beats...
Benzinga Newsdesk
Wednesday, August 07, 2024
Lantern Pharma Announces Significant Advancem...
Benzinga Newsdesk
Monday, August 05, 2024
Lantern Pharma Shares Clinical Update From On...
Benzinga Newsdesk
Wednesday, July 10, 2024
Lantern Pharma Achieves Milestone Towards Dev...
Benzinga Newsdesk
Wednesday, June 12, 2024
Lantern Estimates That LP-284 Can Have The Po...
Benzinga Newsdesk
Lantern Pharma Announced That The Japan Paten...
Benzinga Newsdesk
Monday, May 13, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, May 10, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Lantern Pharma shares are trading lower after...
Benzinga Newsdesk
Thursday, May 09, 2024
Lantern Pharma Q1 2024 GAAP EPS $(0.51) Misse...
Benzinga Newsdesk
Monday, May 06, 2024
Oregon Therapeutics & Lantern Pharma Launch S...
Benzinga Newsdesk
Thursday, April 25, 2024
HC Wainwright & Co. Reiterates Neutral on Lan...
Benzinga Newsdesk
Monday, April 22, 2024
Lantern Pharmashares are trading higher afte...
Benzinga Newsdesk
Lantern Pharma Approved To Expand Harmonic Cl...
Benzinga Newsdesk
Friday, April 19, 2024
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Thursday, April 11, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Tuesday, March 19, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Lantern Pharma shares are trading lower. The ...
Benzinga Newsdesk
Monday, March 18, 2024
Recap: Lantern Pharma Q4 Earnings
Benzinga Insights
Lantern Pharma Q4 2023 GAAP EPS $(0.39) Beats...
Benzinga Newsdesk
Earnings Scheduled For March 18, 2024
Benzinga Insights
Friday, March 15, 2024
Lantern Pharma Earnings Preview
Benzinga Insights
Lantern Pharma Announces Initial Patients Dos...
Benzinga Newsdesk
Monday, March 11, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Friday, March 08, 2024
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Wednesday, March 06, 2024
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Box Reports Upbeat Earnings, Joins American Public Education, Wave Life Sciences And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Monday, March 04, 2024
Lantern Pharma's AI Platform, RADR, Surpasses...
Benzinga Newsdesk
Thursday, February 15, 2024
Lantern Pharma Advances ADC Program Across Mu...
Benzinga Newsdesk
Monday, December 18, 2023
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Thursday, November 30, 2023
FDA Grants Lantern Pharma Orphan Drug Designa...
Benzinga Newsdesk
Tuesday, November 28, 2023
Lantern Pharma Awarded Orphan Designation Sta...
Benzinga Newsdesk
Thursday, November 09, 2023
Lantern Pharma shares are trading higher afte...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, November 08, 2023
Lantern Pharma: Q3 Earnings Insights
Benzinga Insights
Lantern Pharma Q3 2023 Gaap EPS $(0.29) Beats...
Benzinga Newsdesk
Earnings Scheduled For November 8, 2023
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
